Gut Microbiota-derived Propionate Reduces Cancer Cell Proliferation in the Liver

Overview

Journal Br J Cancer

Specialty Oncology

Date 2012 Sep 15

PMID 22976799

Citations 135

Authors

L B Bindels

P Porporato

E M Dewulf

J Verrax

A M Neyrinck

J C Martin

K P Scott

P Buc Calderon

O Feron

G G Muccioli

P Sonveaux

P D Cani

N M Delzenne

Affiliations

Soon will be listed here.

Abstract

Background: Metabolites released by the gut microbiota may influence host metabolism and immunity. We have tested the hypothesis that inulin-type fructans (ITF), by promoting microbial production of short-chain fatty acids (SCFA), influence cancer cell proliferation outside the gut.

Methods: Mice transplanted with Bcr-Abl-transfected BaF3 cells, received ITF in their drinking water. Gut microbiota was analysed by 16S rDNA polymerase chain reaction (PCR)-denaturing gradient gel electrophoresis (DGGE) and qPCR. Serum Short-chain fatty acids were quantified by UHPLC-MS. Cell proliferation was evaluated in vivo, by molecular biology and histology, and in vitro.

Results: Inulin-type fructans treatment reduces hepatic BaF3 cell infiltration, lessens inflammation and increases portal propionate concentration. In vitro, propionate reduces BaF3 cell growth through a cAMP level-dependent pathway. Furthermore, the activation of free fatty acid receptor 2 (FFA2), a Gi/Gq-protein-coupled receptor also known as GPR43 and that binds propionate, lessens the proliferation of BaF3 and other human cancer cell lines.

Conclusion: We show for the first time that the fermentation of nutrients such as ITF into propionate can counteract malignant cell proliferation in the liver tissue. Our results support the interest of FFA2 activation as a new strategy for cancer therapeutics. This study highlights the importance of research focusing on gut microbes-host interactions for managing systemic and severe diseases such as leukaemia.

Citing Articles

Gut microbiota-derived short chain fatty acids act as mediators of the gut-liver-brain axis.

Li C, Yao J, Yang C, Yu S, Yang Z, Wang L Metab Brain Dis. 2025; 40(2):122.

PMID: 39921774 DOI: 10.1007/s11011-025-01554-5.

Black Soybean Seed Coat Extract Suppresses Gut Tumorigenesis by Augmenting the Production of Gut Microbiota-Derived Short-Chain Fatty Acids.

Shimizu Y, Hirano S, Salah M, Hoshi N, Yamashita Y, Fukumoto T Cancers (Basel). 2024; 16(22).

PMID: 39594801 PMC: 11592864. DOI: 10.3390/cancers16223846.

Existence and distribution of the microbiome in tumour tissues of children with hepatoblastoma.

Cui J, Li X, Zhang Q, Du B, Ding Z, Yan C Heliyon. 2024; 10(21):e39547.

PMID: 39553581 PMC: 11564952. DOI: 10.1016/j.heliyon.2024.e39547.

Apoptotic and proliferative processes in the small intestine of rats with type 2 diabetes mellitus after metformin and propionic acid treatment.

Natrus L, Lisakovska O, Smirnov A, Osadchuk Y, Klys Y Front Pharmacol. 2024; 15:1477793.

PMID: 39478962 PMC: 11521949. DOI: 10.3389/fphar.2024.1477793.

The gut microbiome and dietary fibres: implications in obesity, cardiometabolic diseases and cancer.

Delzenne N, Bindels L, Neyrinck A, Walter J Nat Rev Microbiol. 2024; .

PMID: 39390291 DOI: 10.1038/s41579-024-01108-z.

References

Cani P, Neyrinck A, Fava F, Knauf C, Burcelin R, Tuohy K . Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia. 2007; 50(11):2374-83. DOI: 10.1007/s00125-007-0791-0. View

Bindels L, Beck R, Schakman O, Martin J, De Backer F, Sohet F . Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model. PLoS One. 2012; 7(6):e37971. PMC: 3384645. DOI: 10.1371/journal.pone.0037971. View

Pool-Zobel B, Sauer J . Overview of experimental data on reduction of colorectal cancer risk by inulin-type fructans. J Nutr. 2007; 137(11 Suppl):2580S-2584S. DOI: 10.1093/jn/137.11.2580S. View

Ren R . Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer. 2005; 5(3):172-83. DOI: 10.1038/nrc1567. View

Kondegowda N, Meaney M, Baker C, Ju Y . Effects of non-digestible carbohydrates on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice. Nutr Cancer. 2010; 63(1):55-64. DOI: 10.1080/01635581.2010.516871. View

Cani P, Knauf C, Iglesias M, Drucker D, Delzenne N, Burcelin R . Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes. 2006; 55(5):1484-90. DOI: 10.2337/db05-1360. View

Lee T, Schwandner R, Swaminath G, Weiszmann J, Cardozo M, Greenberg J . Identification and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2. Mol Pharmacol. 2008; 74(6):1599-609. DOI: 10.1124/mol.108.049536. View

Louis P, Scott K, Duncan S, Flint H . Understanding the effects of diet on bacterial metabolism in the large intestine. J Appl Microbiol. 2007; 102(5):1197-208. DOI: 10.1111/j.1365-2672.2007.03322.x. View

Cherbut C, Michel C, Lecannu G . The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats. J Nutr. 2003; 133(1):21-7. DOI: 10.1093/jn/133.1.21. View

10.

Daubioul C, Rousseau N, Demeure R, Gallez B, Taper H, Declerck B . Dietary fructans, but not cellulose, decrease triglyceride accumulation in the liver of obese Zucker fa/fa rats. J Nutr. 2002; 132(5):967-73. DOI: 10.1093/jn/132.5.967. View

11.

Siavoshian S, Segain J, Kornprobst M, Bonnet C, Cherbut C, Galmiche J . Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. Gut. 2000; 46(4):507-14. PMC: 1727889. DOI: 10.1136/gut.46.4.507. View

12.

Tang Y, Chen Y, Jiang H, Robbins G, Nie D . G-protein-coupled receptor for short-chain fatty acids suppresses colon cancer. Int J Cancer. 2010; 128(4):847-56. DOI: 10.1002/ijc.25638. View

13.

Guarner F, Malagelada J . Gut flora in health and disease. Lancet. 2003; 361(9356):512-9. DOI: 10.1016/S0140-6736(03)12489-0. View

14.

Tolhurst G, Heffron H, Lam Y, Parker H, Habib A, Diakogiannaki E . Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. 2011; 61(2):364-71. PMC: 3266401. DOI: 10.2337/db11-1019. View

15.

Aoyama M, Kotani J, Usami M . Butyrate and propionate induced activated or non-activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41/GPR-43 pathways. Nutrition. 2009; 26(6):653-61. DOI: 10.1016/j.nut.2009.07.006. View

16.

Le Poul E, Loison C, Struyf S, Springael J, Lannoy V, Decobecq M . Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem. 2003; 278(28):25481-9. DOI: 10.1074/jbc.M301403200. View

17.

Brown A, Goldsworthy S, Barnes A, Eilert M, Tcheang L, Daniels D . The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem. 2002; 278(13):11312-9. DOI: 10.1074/jbc.M211609200. View

18.

Fiskus W, Pranpat M, Bali P, Balasis M, Kumaraswamy S, Boyapalle S . Combined effects of novel tyrosine kinase inhibitor AMN107 and histone deacetylase inhibitor LBH589 against Bcr-Abl-expressing human leukemia cells. Blood. 2006; 108(2):645-52. DOI: 10.1182/blood-2005-11-4639. View

19.

Bray J, Sludden J, Griffin M, Cole M, Verrill M, Jamieson D . Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide. Br J Cancer. 2010; 102(6):1003-9. PMC: 2844036. DOI: 10.1038/sj.bjc.6605587. View

20.

Hong Y, Nishimura Y, Hishikawa D, Tsuzuki H, Miyahara H, Gotoh C . Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology. 2005; 146(12):5092-9. DOI: 10.1210/en.2005-0545. View